WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell® Wearable Pain Relief Technology™ will be featured at the Midwest Podiatry Conference to be held March 31-April 3 at the Hyatt Regency Chicago.
“Podiatrists are at the front lines in treating chronic pain, with 77% of American adults suffering from foot pain,” says Frank McGillin, Senior Vice President and General Manager, Consumer of NeuroMetrix. “Every day we see more and more healthcare professionals integrating Quell’s 100% drug free technology into their treatment protocols. Quell was recently awarded the American Podiatric Medical Association (APMA) Seal of Approval, which helps podiatrists feel confident that they are offering patients an innovative, clinically proven way to manage their chronic pain.”
